Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357849 · ClinicalTrials.gov registry record · Phase 4
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
A Phase 4 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT02357849 is a Phase 4 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 9 participants.
The verdict
NCT02357849, a Phase 4 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.
Interventions
- DRUG Fluoxetine
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-07 |
| Est. Completion | 2022-04-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02357849
The ClinicalTrials.gov registry entry for NCT02357849 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluoxetine is the first listed.
NCT02357849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02357849 about?
NCT02357849 is a clinical study titled "Fluoxetine vs Aripiprazole Comparative Trial (FACT)". We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.
What is the current status of trial NCT02357849?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2014-07. Estimated completion is 2022-04-04.
What interventions are being tested in trial NCT02357849?
The interventions under investigation include: Fluoxetine (DRUG), Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT02357849?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.